(Q34112793)

English

Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiency

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiency (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

Jordan S. Orange

8

object named as

Jordan S Orange

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

John B Hagan

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Mary B Fasano

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sheldon Spector

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Richard L Wasserman

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Isaac Melamed

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Mikhail A Rojavin

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Othmar Zenker

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

8 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Journal of Clinical Immunology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

734-745

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

https://scigraph.springernature.com/pub.10.1007/s10875-010-9423-4

0 references

Subcutaneous administration of IgG.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

5 July 2018

Common variable immunodeficiency: a new look at an old disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

5 July 2018

Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

5 July 2018

Replacement IgG therapy and self-therapy at home improve the health-related quality of life in patients with primary antibody deficiencies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

5 July 2018

IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

5 July 2018

The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

5 July 2018

Primary immunodeficiency diseases due to defects in lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

5 July 2018

The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

5 July 2018

Slow subcutaneous human intravenous immunoglobulin in the treatment of antibody immunodeficiency: use of an old method with a new product

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

5 July 2018

Human intravenous immunoglobulin in primary and secondary antibody deficiencies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

5 July 2018

Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

5 July 2018

Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

5 July 2018

Case-control study of thromboembolic events associated with IV immunoglobulin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

28 October 2018

Safety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficiencies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

28 October 2018

Investigations of prion and virus safety of a new liquid IVIG product.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

28 October 2018

Myocardial infarction during intravenous immunoglobulin infusion in a 65-year-old man with common variable immunodeficiency and subsequent successful repeated administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

28 October 2018

Patients' attitude to subcutaneous immunoglobulin substitution as home therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

28 October 2018

Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

28 October 2018

Efficacy, safety and tolerability of a new 10% liquid intravenous immune globulin [IGIV 10%] in patients with primary immunodeficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

28 October 2018

Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

28 October 2018

Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

28 October 2018

Common variable immunodeficiency: clinical and immunological features of 248 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

28 October 2018

Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935975

28 October 2018

Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20454851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/20454851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Express subcutaneous IgG infusions: decreased time of delivery with maintained safety

1 reference

https://pubmed.ncbi.nlm.nih.gov/20454851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary immunodeficiency diseases: an update

1 reference

https://pubmed.ncbi.nlm.nih.gov/20454851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute thromboembolic events associated with intravenous immunoglobulin infusion in antibody-deficient patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20454851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Slow subcutaneous immunoglobulin therapy in a patient with reactions to intramuscular immunoglobulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/20454851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: A retrospective survey of 31 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20454851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies--a prospective, multi-national study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20454851

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10875-010-9423-4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34112793&oldid=1405963525"